Trading Signals: BCRX Stock Price Prediction and Forecast (Tue. Sep. 2, 2003 - Wed. Sep. 27, 2023)(BioCryst Pharmaceuticals, Inc.)
| BCRX latest price $12.1850 (-5.65%) ($12.1850 - $12.1850) on Thu. Nov. 17, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.37% (three month average) | RSI | 39 | Latest Price | $12.1850(-5.65%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | BCRX declines -1.1% a day on average for past five trading days. | Weekly Trend | BCRX advances 1.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support BCRX advance at 0% a week (0% probability) XLK(28%) URA(27%) VUG(27%) VT(25%) XHB(23%) | Factors Impacting BCRX price | BCRX will decline at least -1.685% in a week (0% probabilities). SMH(-18%) VIXM(-12%) UUP(-4%) ARKG(-4%) VXX(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.685% (StdDev 3.37%) | Hourly BBV | -1.7 () | Intraday Trend | 0% | | | |
|
Resistance Level | $12.92 | 5 Day Moving Average | $13.06(-6.7%) | 10 Day Moving Average | $12.66(-3.75%) | 20 Day Moving Average | $12.92(-5.69%) | To recent high | -17.8% | To recent low | 3.8% | Market Cap | $2.15b | | | | BioCryst Pharmaceuticals, Inc. designs and develops novel, oral and small-molecule medicines. Its drug candidates include Berotralstat, BCX9930, BCX9250, RAPIVAB, ALPIVAB, RAPIACTA, PERAMIFLU, Galidesivir and Mundesine. The company was founded in 1986 and is headquartered in Durham, NC. |